877202-74-9

Basic information

• Product Name: 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea
• Synonyms: 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea;PSNCBAM 1;N-(4-Chlorophenyl)-N′-[3-[6-(1-pyrrolidinyl)-2-pyridinyl]phenyl]-urea
• CAS NO: 877202-74-9
• Molecular Formula: C22H21ClN4O
• Molecular Weight: 392.88134
• Mol File: 877202-74-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 521.5±50.0 °C(Predicted)
• Appearance: white to beige/
• Density: 1.332
• Storage Temp.: 2-8°C
• Solubility: DMSO: soluble15mg/mL (clear solution)
• PKA: 13.45±0.70(Predicted)
• CAS DataBase Reference: 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea(877202-74-9)
• EPA Substance Registry System: 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea(877202-74-9)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 877202-74-9(Hazardous Substances Data)

Usage

Description

1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea is a chemical compound that belongs to the class of urea derivatives. It is characterized by the presence of chlorophenyl, pyridyl, and pyrrolidinyl moieties in its molecular structure. 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea has garnered interest due to its potential pharmaceutical applications, particularly in the treatment of various diseases such as cancer and neurodegenerative disorders. The unique structural features of 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea make it a promising candidate for further investigation and potential development as a drug candidate.

Uses

Used in Pharmaceutical Industry:
1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea is used as a therapeutic agent for the treatment of various diseases. Its application is primarily due to its potential in targeting and treating cancer and neurodegenerative disorders. 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea's unique structural features allow it to interact with specific biological targets, making it a valuable candidate for drug development.
Used in Cancer Treatment:
In the field of oncology, 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea is used as an anticancer agent. It has been studied for its potential to target and inhibit the growth of cancer cells, making it a promising candidate for the development of novel cancer therapies. 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea's ability to interact with specific cellular targets and modulate signaling pathways involved in cancer progression contributes to its potential as an effective treatment option.
Used in Neurodegenerative Disorder Treatment:
1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea is also being investigated for its potential use in the treatment of neurodegenerative disorders. These conditions are characterized by the progressive loss of nerve cells, leading to the decline of cognitive and motor functions. 1-(4-Chlorophenyl)-3-[3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl]urea's unique structural features and potential to modulate cellular pathways involved in neurodegeneration make it a promising candidate for the development of novel therapeutic strategies to combat these debilitating diseases.